American National Insurance’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.47M | Sell |
21,426
-4,934
| -19% | -$717K | 0.94% | 20 |
|
|
2021
Q4 | $3.57M | Sell |
26,360
-128,298
| -83% | -$15.2M | 0.79% | 21 |
|
|
2021
Q3 | $16.7M | Sell |
154,658
-155
| -0.1% | -$17.7K | 0.63% | 36 |
|
|
2021
Q2 | $17.4M | Sell |
154,813
-270
| -0.2% | -$30.4K | 0.65% | 30 |
|
|
2021
Q1 | $16.8M | Sell |
155,083
-123
| -0.1% | -$13.2K | 0.69% | 29 |
|
|
2020
Q4 | $16.6M | Hold |
155,206
| – | – | 0.71% | 28 |
|
|
2020
Q3 | $13.6M | Hold |
155,206
| – | – | 0.65% | 39 |
|
|
2020
Q2 | $15.2M | Buy |
155,206
+26,216
| +20% | +$2.31M | 0.79% | 26 |
|
|
2020
Q1 | $9.83M | Hold |
128,990
| – | – | 0.63% | 45 |
|
|
2019
Q4 | $11.4M | Sell |
128,990
-11,000
| -8% | -$913K | 0.59% | 51 |
|
|
2019
Q3 | $10.6M | Hold |
139,990
| – | – | 0.56% | 54 |
|
|
2019
Q2 | $10.2M | Hold |
139,990
| – | – | 0.54% | 56 |
|
|
2019
Q1 | $11.3M | Hold |
139,990
| – | – | 0.59% | 54 |
|
|
2018
Q4 | $12.9M | Hold |
139,990
| – | – | 0.75% | 37 |
|
|
2018
Q3 | $13.2M | Sell |
139,990
-20,000
| -13% | -$1.9M | 0.65% | 45 |
|
|
2018
Q2 | $14.8M | Hold |
159,990
| – | – | 0.73% | 34 |
|
|
2018
Q1 | $15.1M | Hold |
159,990
| – | – | 0.77% | 31 |
|
|
2017
Q4 | $15.5M | Hold |
159,990
| – | – | 0.78% | 30 |
|
|
2017
Q3 | $14.2M | Sell |
159,990
-4,500
| -3% | -$343K | 0.75% | 36 |
|
|
2017
Q2 | $11.9M | Hold |
164,490
| – | – | 0.65% | 50 |
|
|
2017
Q1 | $10.7M | Hold |
164,490
| – | – | 0.59% | 52 |
|
|
2016
Q4 | $10.3M | Hold |
164,490
| – | – | 0.6% | 51 |
|
|
2016
Q3 | $10.4M | Hold |
164,490
| – | – | 0.6% | 48 |
|
|
2016
Q2 | $10.2M | Hold |
164,490
| – | – | 0.6% | 48 |
|
|
2016
Q1 | $9.4M | Sell |
164,490
-510
| -0.3% | -$28.4K | 0.56% | 50 |
|
|
2015
Q4 | $9.78M | Hold |
165,000
| – | – | 0.58% | 49 |
|
|
2015
Q3 | $8.98M | Hold |
165,000
| – | – | 0.57% | 53 |
|
|
2015
Q2 | $11.1M | Hold |
165,000
| – | – | 0.66% | 44 |
|
|
2015
Q1 | $9.66M | Hold |
165,000
| – | – | 0.57% | 55 |
|
|
2014
Q4 | $10.8M | Hold |
165,000
| – | – | 0.64% | 46 |
|
|
2014
Q3 | $9.53M | Hold |
165,000
| – | – | 0.58% | 51 |
|
|
2014
Q2 | $9.31M | Hold |
165,000
| – | – | 0.56% | 54 |
|
|
2014
Q1 | $8.48M | Hold |
165,000
| – | – | 0.54% | 56 |
|
|
2013
Q4 | $8.71M | Hold |
165,000
| – | – | 0.56% | 51 |
|
|
2013
Q3 | $7.38M | Hold |
165,000
| – | – | 0.53% | 58 |
|
|
2013
Q2 | $6.82M | Buy |
+165,000
| New | +$7.22M | 0.51% | 58 |
|
Other funds holding ABBV
American National Insurance's ABBV Position: Q1 2022 in Review
American National Insurance reduced its AbbVie (ABBV) stake by 19% in Q1 2022, selling an estimated $717K and leaving 21,426 shares worth $3.47M. The position accounts for 0.94% of the portfolio, ranked #20.
American National Insurance first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $17.4M in Q2 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- American National Insurance held 21,426 shares of AbbVie worth $3.47M as of Q1 2022.
- American National Insurance sold 4,934 AbbVie shares in Q1 2022, an estimated $717K.
- AbbVie made up 0.94% of American National Insurance's portfolio in Q1 2022, its #20 holding.
- American National Insurance first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- American National Insurance's AbbVie position peaked at $17.4M in Q2 2021.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.